electroCore (ECOR) Scheduled to Post Earnings on Wednesday

electroCore (NASDAQ:ECOR - Get Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, November 13th. Analysts expect the company to announce earnings of ($0.28) per share for the quarter. Individual that are interested in registering for the company's earnings conference call can do so using this link.

electroCore (NASDAQ:ECOR - Get Free Report) last released its earnings results on Wednesday, August 7th. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.39) by $0.01. electroCore had a negative return on equity of 165.17% and a negative net margin of 66.84%. The company had revenue of $6.14 million for the quarter, compared to analyst estimates of $5.85 million. During the same period in the prior year, the firm posted ($1.03) EPS. On average, analysts expect electroCore to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

electroCore Price Performance

ECOR traded down $0.70 on Wednesday, hitting $12.06. 136,887 shares of the stock were exchanged, compared to its average volume of 21,979. The firm has a market capitalization of $77.75 million, a price-to-earnings ratio of -5.80 and a beta of 0.56. electroCore has a 12 month low of $5.02 and a 12 month high of $13.25. The business has a 50-day moving average of $7.82 and a two-hundred day moving average of $6.84.

Insider Buying and Selling

In other electroCore news, Director Thomas J. Errico bought 5,000 shares of the firm's stock in a transaction on Thursday, August 15th. The shares were purchased at an average price of $6.12 per share, for a total transaction of $30,600.00. Following the completion of the transaction, the director now directly owns 233,818 shares in the company, valued at approximately $1,430,966.16. The trade was a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. 19.70% of the stock is currently owned by company insiders.

electroCore Company Profile

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.